Literature DB >> 30909261

Comparison of the firefighter candidate physical ability test to weight lifting exercises using electromyography.

Charity L Lane1,2, Dustin Hardwick3, Thomas P Janus3, Henian Chen4, Yuanyuan Lu4, John M Mayer1,2.   

Abstract

BACKGROUND: Muscular strength and endurance are important attributes for structural firefighting. Matching resistance exercises to firefighter job demands is not well-established.
OBJECTIVE: This study compared the electromyographic (EMG) activity of major muscles during the Candidate Physical Ability Test (CPAT) and weight lifting exercises in firefighters.
METHODS: A repeated measures study was conducted in 13 full-duty career firefighters (1 F, 12 M; age 18-44 years). Participants completed seven weight lifting exercises at a university laboratory. They separately completed the CPAT at a firefighting training grounds. During each activity, surface EMG (% maximum voluntary isometric contraction - MVIC) of major muscle groups was recorded and compared between exercises and CPAT.
RESULTS: No difference in EMG activity was observed between exercises and CPAT for the deltoid, trapezius, lumbar multifidus, gluteal, and biceps femoris muscles. EMG activity was significantly greater during the CPAT for the abdominal obliques (32.3% ±27.7% vs. 12.1% ±8.3%, p <  0.001) and for the latissimus dorsi (21.8% ±25.1% vs. 11.4% ±7.7%, p <  0.001).
CONCLUSIONS: Standard weight lifting and abdominal oblique exercises should be incorporated into resistance training programs for firefighters.

Entities:  

Keywords:  Muscle activation; first responders; job related exercise; occupational injuries; resistance training; tactical athletes

Mesh:

Year:  2019        PMID: 30909261     DOI: 10.3233/WOR-192880

Source DB:  PubMed          Journal:  Work        ISSN: 1051-9815


  1 in total

1.  Comprehensive Assessment of Implementation Factors Related to Worksite Exercise in Firefighters.

Authors:  Charity L Lane; O'Dane Brady; John M Mayer
Journal:  J Occup Environ Med       Date:  2022-01-01       Impact factor: 2.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.